NFKB1 and COVID-19: Statins have been shown to modulate the MYD88–NF-κB proinflammatory pathway, upregulate ACE2, and have anti-thrombotic properties, mainly through their effects on platelet function, all potentially important effects on patients with severe cases of COVID-19 (20, 23).